{"adrenal insufficiency": 8.26, "adverse drug reaction": 2.0, "alanine aminotransferase increased": 4.01, "amylase increased": 3.88, "anal fistula": 9.59, "aortic dissection": 5.71, "ascites": 4.82, "aspartate aminotransferase increased": 4.92, "blister": 2.48, "blood albumin decreased": 4.76, "blood calcium decreased": 5.31, "blood potassium decreased": 2.3, "blood pressure increased": 3.76, "blood sodium decreased": 2.28, "blood thyroid stimulating hormone increased": 13.16, "bone lesion": 7.34, "cancer pain": 22.54, "cholangitis": 7.24, "cholecystitis": 2.2, "clear cell renal cell carcinoma": 21.17, "colitis": 2.19, "constipation": 3.74, "decreased appetite": 6.01, "dehydration": 2.79, "dermatitis acneiform": 4.74, "diarrhoea": 5.29, "disease progression": 10.77, "dry skin": 5.67, "dysgeusia": 3.46, "dysphonia": 7.19, "enterocolitis": 3.38, "gastric ulcer": 2.56, "gastrointestinal perforation": 11.44, "gastrointestinal toxicity": 6.36, "gastrooesophageal reflux disease": 2.06, "general physical health deterioration": 2.01, "glossodynia": 2.56, "hair colour changes": 29.59, "hepatic cancer": 7.55, "hepatic cytolysis": 3.31, "hepatic encephalopathy": 7.92, "hepatic enzyme increased": 2.67, "hepatic function abnormal": 13.13, "hepatocellular carcinoma": 31.58, "hepatotoxicity": 3.12, "hyperkalaemia": 2.07, "hyperkeratosis": 14.27, "hypertension": 7.04, "hyperthyroidism": 6.66, "hypertransaminasaemia": 6.37, "hypoalbuminaemia": 5.28, "hypocalcaemia": 9.8, "hypomagnesaemia": 11.86, "hyponatraemia": 3.03, "hypothyroidism": 34.18, "immune-mediated enterocolitis": 3.38, "immune-mediated hepatic disorder": 8.16, "immune-mediated lung disease": 3.67, "impaired healing": 8.66, "inappropriate schedule of product administration": 2.85, "interstitial lung disease": 3.64, "intestinal metastasis": 35.51, "intestinal perforation": 4.9, "laboratory test abnormal": 2.59, "large intestine perforation": 9.46, "liver disorder": 8.51, "liver function test increased": 3.55, "malignant neoplasm progression": 10.96, "malignant pleural effusion": 9.66, "metastases to bone": 15.4, "metastases to central nervous system": 7.36, "metastases to liver": 5.16, "metastases to lung": 15.79, "metastases to lymph nodes": 5.42, "metastases to pancreas": 45.27, "metastases to spine": 12.82, "metastasis": 3.0, "metastatic renal cell carcinoma": 16.85, "mucosal inflammation": 13.74, "nephrotic syndrome": 6.39, "off label use": 2.13, "oral discomfort": 2.33, "oral pain": 5.21, "osteonecrosis of jaw": 16.26, "palmar-plantar erythrodysaesthesia syndrome": 70.22, "performance status decreased": 3.14, "platelet count decreased": 3.42, "pleural effusion": 2.04, "pneumatosis intestinalis": 12.93, "pneumonia aspiration": 2.76, "pneumonia bacterial": 3.76, "pneumothorax": 3.24, "posterior reversible encephalopathy syndrome": 4.86, "product prescribing issue": 6.21, "protein urine present": 16.22, "proteinuria": 29.9, "pulmonary mass": 2.38, "renal cancer": 17.74, "renal cancer metastatic": 48.12, "renal cell carcinoma": 81.93, "renal cell carcinoma recurrent": 127.86, "renal impairment": 3.79, "skin disorder": 2.19, "skin exfoliation": 2.78, "skin toxicity": 12.86, "skin ulcer": 9.33, "small intestinal perforation": 12.77, "stomatitis": 15.09, "taste disorder": 15.02, "thyroid disorder": 6.73, "thyroiditis": 7.97, "tooth disorder": 3.81, "transaminases increased": 2.54, "tumour haemorrhage": 8.22, "tumour necrosis": 18.79, "weight decreased": 4.54}